The medical device industry has experienced consistent growth year over year, yet BDX stock has grown < 1% over the past 5 years.
This poor performance is due to weak and naive leadership that learns and then obsesses about basic principles like kaizen (which has been around for decades and should have always been a basic way of working).
Last year leadership came to the amazing revelation that they need to focus on marketing and revenue growth! This of course only happened after the stock plummeted.
lol.
The company has a low level of debt relative to equity which would make it ripe for acquisition but with this place, nothing would surprise me.
It all depends on the BOD and how much longer they’re willing to tolerate the CEO and the company’s underperformance.